 
Assoc. Professor In Residence
      
            M_MED-VAMC-DGIM
      
            
      Dr. Bauer is a general internist, translational epidemiologist, and clinician investigator. He is also a member of the Baker Aging Research Institute (https://geroscience.ucsf.edu), the Kidney Health Research Collective (https://khrc.ucsf.edu/), and the Women's Health Clinical Research Center (https://whcrc.ucsf.edu/). His academic focus is to understand the mechanisms underlying urologic aging and to define clinical phenotypes and biomarkers for older adults with debilitating urologic conditions. Dr. Bauer's areas of research expertise include geriatric urology, lifestyle and age-related risk factors, and longitudinal assessment of biomarkers, functional outcomes, and quality of life.
Publications
Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study.
Nature communications
      
            
      
      Aging-Related Mitochondrial Dysfunction is Associated with Fibrosis in Benign Prostatic Hyperplasia.
Interpreting Geroscience-Guided Biomarker Studies.
M_MED-CORE-DGIM
      
            
      
      Lower urinary tract symptoms and incident functional limitations among older community-dwelling men.
Editorial Comment.
Clinical ophthalmology (Auckland, N.Z.)
      
      Association of Diet With Erectile Dysfunction Among Men in the Health Professionals Follow-up Study.
Association of Lower Urinary Tract Symptom Severity with Kidney Function among Community Dwelling Older Men.
Clinical ophthalmology (Auckland, N.Z.)
      
            
      
      Urinary Incontinence and Nocturia in Older Men: Associations with Body Mass, Composition, and Strength in the Health, Aging, and Body Composition Study.
Clinical ophthalmology (Auckland, N.Z.)
      
            
      
      Setting the Record Straight on FDA Approvals in Oncology-Reply.
M_MED-CORE-DGIM
      
            
      
      Withholding Proton Pump Inhibitors to Prevent Recurrent Clostridium difficile: Time for a Randomized Trial.
M_MED-CORE-DGIM
      
            
      
      Improving the Accelerated Pathway to Cancer Drug Approvals.
M_MED-CORE-DGIM
      
            
      
      